Literature DB >> 338248

Test for cryopreservation efficiency of human acute myelogenous leukaemia cells relevant to clinical requirements.

B Chapuis, B M Summersgill, P Cocks, P Howard, S D Lawler, P Alexander, R Powles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 338248     DOI： 10.1016/0011-2240(77)90018-9

Source DB:  PubMed          Journal:  Cryobiology        ISSN： 0011-2240            Impact factor:   2.487


× No keyword cloud information.
  5 in total

1.  Human spleen as a source of T cell growth factor.

Authors:  A Moretta; M Colombatti; B Chapuis
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

2.  Inability to demonstrate lytic antibodies to autologous leukaemia cells in the sera from remission patients with acute myelogenous leukaemia treated with active specific immunotherapy.

Authors:  B J Chapuis; R Powles; P Alexander
Journal:  Clin Exp Immunol       Date:  1978-05       Impact factor: 4.330

3.  2nd Gordon Hamilton Fairley lecture. Need for new approaches to the treatment of patients in clinical remission, with special reference to acute myeloid leukaemia.

Authors:  P Alexander
Journal:  Br J Cancer       Date:  1982-08       Impact factor: 7.640

4.  Failure to detect autologous antibodies in the remission sera of patients with AML: complications introduced by the presence of rheumatoid factor.

Authors:  S E James; C J Dean; P Alexander
Journal:  Br J Cancer       Date:  1980-09       Impact factor: 7.640

5.  Patterns of maturation in short-term culture of human acute myeloid leukaemic cells.

Authors:  G Palú; R Powles; P Selby; B M Summersgill; P Alexander
Journal:  Br J Cancer       Date:  1979-11       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.